Literature DB >> 8588125

Characterization of B-cell lines from SLE patients and their relatives.

T Witte1, K Hartung, F M Bode, R E Schmidt, H Deicher.   

Abstract

Epstein-Barr-virus (EBV)-transformed lymphoblastoid B-cell lines were generated from peripheral blood lymphocytes of 55 patients with systemic lupus erythematosus (SLE) and 44 healthy relatives. All donors have previously been extensively characterized with regard to clinical, serologic, and genetic parameters. Here, peripheral blood lymphocytes and lines were characterized for cell surface antigens. Furthermore, autoantibody production and proliferation rate of the cell lines were monitored. A significant difference between patients and relatives was the lower proliferation rate of EBV-transformed cell lines of the SLE patients. All SLE cell lines are available for interested researches and can be obtained from the European Cell Bank, Salisbury, UK.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8588125     DOI: 10.1007/bf00302123

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  27 in total

1.  Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.

Authors:  J Avila-Cariño; S Torsteinsdottir; B Ehlin-Henriksson; M G Masucci; E Klein
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

2.  Defect of a complement receptor 3 epitope in a patient with systemic lupus erythematosus.

Authors:  T Witte; F L Dumoulin; J E Gessner; J Schubert; O Götze; C Neumann; R F Todd; H Deicher; R E Schmidt
Journal:  J Clin Invest       Date:  1993-09       Impact factor: 14.808

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  Quantitation of IgM- and IgG-secreting B cells in the peripheral blood of patients with systemic lupus erythematosus.

Authors:  D M Klinman; A Shirai; Y Ishigatsubo; J Conover; A D Steinberg
Journal:  Arthritis Rheum       Date:  1991-11

5.  Abnormal production of B cell growth factor in patients with systemic lupus erythematosus.

Authors:  N Ogawa; M Itoh; Y Goto
Journal:  Clin Exp Immunol       Date:  1992-07       Impact factor: 4.330

6.  Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.

Authors:  G Miller; M Lipman
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

7.  Effects of IL-4, IL-5, and IL-6 on growth and immunoglobulin production of Epstein-Barr virus-infected human B cells.

Authors:  R J Bende; G J Jochems; T H Frame; M R Klein; R V van Eijk; R A van Lier; W P Zeijlemaker
Journal:  Cell Immunol       Date:  1992-09       Impact factor: 4.868

8.  MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.

Authors:  P von Wussow; D Jakschies; H Hochkeppel; M Horisberger; K Hartung; H Deicher
Journal:  Arthritis Rheum       Date:  1989-07

9.  Precursor frequencies for DNA-specific B lymphocytes in patients with systemic lupus erythematosus (SLE).

Authors:  J Schwab; A Lukowsky; H D Volk; H H Peter; I Melchers
Journal:  Clin Exp Immunol       Date:  1994-06       Impact factor: 4.330

10.  Structure and expression of human IgG FcRII(CD32). Functional heterogeneity is encoded by the alternatively spliced products of multiple genes.

Authors:  D G Brooks; W Q Qiu; A D Luster; J V Ravetch
Journal:  J Exp Med       Date:  1989-10-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.